Bimodal expression of potential drug target CLL‐1 (CLEC12A) on CD34+ blasts of AML patients-Reference-Cited by-同舟云学术

Bimodal expression of potential drug target CLL‐1 (CLEC12A) on CD34+ blasts of AML patients

Published:2021-06-26 Issue:3 Volume:107 Page:343-353
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Ngai Lok Lam¹,Ma Connie Y.²,Maguire Orla³,Do An D.²^ORCID,Robert Alberto²,Logan Aaron C.⁴^ORCID,Griffiths Elizabeth A.³,Nemeth Michael J.³,Green Cherie²,Pourmohamad Tony⁵,van Kuijk Bo J.¹,Snel Alexander N.¹,Kwidama Zinia W.¹,Venniker‐Punt Bianca¹,Cooper James⁶,Manz Markus G.⁷,Gjertsen Bjørn T.⁸,Smit Linda¹,Ossenkoppele Gert J.¹,Janssen Jeroen J. W. M.¹,Cloos Jacqueline¹,Sumiyoshi Teiko²

Affiliation:

1. Department of Hematology Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam The Netherlands

2. Department of Development of Science Genentech South San Francisco CA USA

3. Flow and Image Cytometry Shared Resource Buffalo NY USA

4. Department of Medicine UCSF San Francisco CA USA

5. Department of Biostatistics Genentech CA USA

6. Department of Early Clinical Development Genentech South San Francisco CA USA

7. Department of Medical Oncology and Hematology University and University Hospital Zurich Switzerland

8. Section for Hematology Institute of Clinical Science University of Bergen Bergen Norway

Funder

National Cancer Institute

Publisher